Eli Lilly and Company Earnings
The next earnings date for Eli Lilly and Company has not yet been scheduled.
Analyst Estimates of Eli Lilly and Company Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Eli Lilly and Company Earnings: Historical
| 08/05/2026 | Before Market | --- | --- |
| 04/30/2026 | Before Market | $8.55 | 25.92% |
| 02/04/2026 | Before Market | $7.54 | 5.16% |
| 10/30/2025 | Before Market | $7.02 | 19.19% |
| 08/07/2025 | Before Market | $6.31 | 12.48% |
| 05/01/2025 | Before Market | $3.34 | -3.47% |
| 02/06/2025 | Before Market | $5.32 | 5.00% |
| 10/30/2024 | Before Market | $1.18 | -19.73% |
| 08/08/2024 | Before Market | $3.92 | 41.52% |
| 04/30/2024 | Before Market | $2.58 | 3.61% |
More About Eli Lilly and Company
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
“Eli Lilly and Company Earnings” Can Refer to the Eli Lilly and Company Earnings Date
Some people say “Eli Lilly and Company earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Eli Lilly and Company position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Eli Lilly and Company Stock on the Earnings Date
If you own Eli Lilly and Company stock (LLY) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Eli Lilly and Company might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Eli Lilly and Company shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Owning Eli Lilly and Company Options on the Earnings Date
If you own Eli Lilly and Company options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
In addition, the extrinsic values of Eli Lilly and Company options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own Eli Lilly and Company options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.
This makes sense considering that prices are often more volatile on earnings dates for Eli Lilly and Company. That potential volatility is a key factor that affects the premium cost of owning options.
Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of Eli Lilly and Company options often go down. This is sometimes referred to as volatility crush.
Learning More Eli Lilly and Company Earnings
You can contact us any time if you would like to ask questions about Eli Lilly and Company earnings or anything else related to the stock market.